THE WALL HOUSE SURGERY
YORKE ROAD, REIGATECKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CKD 4 | 2007 | 88 | 92 | 95.7% | |
CKD 4 | 2008 | 145 | 164 | 88.4% | |
CKD 5 | 2009 | 18 | 22 | 81.8% | |
CKD 5 | 2010 | 13 | 15 | 86.7% | |
CKD 5 | 2011 | 15 | 17 | 88.2% | |
CKD 5 | 2012 | 23 | 23 | 100.0% | |
CKD 5 | 2013 | 25 | 29 | 86.2% | |
CKD003 | 2014 | 33 | 36 | 91.7% | |
CKD003 | 2015 | 31 | 34 | 91.2% | |
NM84 | 2016 | 31 | 40 | 77.5% | |
NM84 | 2017 | 28 | 38 | 73.7% | |
NM84 | 2018 | 29 | 38 | 76.3% | |
NM84 | 2019 | 18 | 25 | 72.0% | |
NM84 | 2022 | 18 | 25 | 72.0% | |
NM84 | 2023 | 16 | 26 | 61.5% |